(Total Views: 485)
Posted On: 07/01/2023 4:02:11 PM
Post# of 153992
That's what Cyrus said last December: we need to generate robust data.
This has been major reclamation project. We all know the lousy position Nader and Amarex put us in with regards to the data we have and where we should have been by this point but it's still going to take time.
Per the last call, work has progressed with the FDA's hepatology department and the projection for the NASH trial start wasn't until Q3 (still not sure if calendar or fiscal) so we should hear more whenever we get our next update.
This has been major reclamation project. We all know the lousy position Nader and Amarex put us in with regards to the data we have and where we should have been by this point but it's still going to take time.
Per the last call, work has progressed with the FDA's hepatology department and the projection for the NASH trial start wasn't until Q3 (still not sure if calendar or fiscal) so we should hear more whenever we get our next update.
(5)
(0)
